LifePoint Health, Inc. (LPNT) Receives “Hold” Rating from SunTrust Banks, Inc.
SunTrust Banks, Inc. reaffirmed their hold rating on shares of LifePoint Health, Inc. (NASDAQ:LPNT) in a report published on Thursday. SunTrust Banks, Inc. currently has a $63.00 price target on the stock.
LPNT has been the topic of a number of other research reports. BidaskClub cut LifePoint Health from a buy rating to a hold rating in a report on Saturday, July 8th. Royal Bank Of Canada reaffirmed a buy rating and issued a $77.00 price target on shares of LifePoint Health in a report on Wednesday, July 5th. Zacks Investment Research raised LifePoint Health from a hold rating to a buy rating and set a $75.00 price target on the stock in a report on Tuesday, July 4th. TheStreet cut LifePoint Health from a b- rating to a c+ rating in a report on Wednesday, August 16th. Finally, ValuEngine cut LifePoint Health from a buy rating to a hold rating in a report on Friday, September 1st. Four analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of $66.33.
LifePoint Health (LPNT) opened at 55.00 on Thursday. LifePoint Health has a 12 month low of $50.60 and a 12 month high of $70.95. The company has a market cap of $2.21 billion, a PE ratio of 12.32 and a beta of 0.84. The company has a 50 day moving average price of $56.57 and a 200-day moving average price of $61.04.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.06. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.69 EPS. Equities analysts predict that LifePoint Health will post $4.06 earnings per share for the current fiscal year.
Institutional investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of LifePoint Health by 10.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares during the last quarter. LS Investment Advisors LLC increased its position in shares of LifePoint Health by 43.7% during the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after purchasing an additional 543 shares during the last quarter. US Bancorp DE increased its position in shares of LifePoint Health by 1.6% during the 1st quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after purchasing an additional 30 shares during the last quarter. Shelton Capital Management bought a new position in shares of LifePoint Health during the 2nd quarter valued at about $205,000. Finally, Teacher Retirement System of Texas bought a new position in shares of LifePoint Health during the 1st quarter valued at about $210,000. Hedge funds and other institutional investors own 99.53% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Stock Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related stocks with our FREE daily email newsletter.